Robert Holloway, MD to Have Manuscript Published in the Oncologist

Choose the health content that's right for you, and get it delivered right in your inbox

Dr. Robert Holloway’s manuscript titled, “Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination With Carboplatin Versus Gemcitabine/Carboplatin for the Treatment of Platinum Sensitive Recurrent Ovarian Cancer: A Systematic Review,” has been accepted for publication by The Oncologist- The official journal of the Society for Translational Oncology. This manuscript was reviewed by Section Editors at The Oncologist and other external experts in the field.

Congratulations to Dr. Holloway for the scientific advancement that this manuscript represents.

Tuesday, October 25, 2011

Recent Blogs

A child on the monkey bars with the help of his mother
Blog
Fall Candy Galore: Keep Kids Well With Healthy Alternatives
African American woman get's a flu shot at a drive through location
Blog
Why Getting a Flu Shot Is More Important Than Ever
Blog
Pink Fire Truck Named After Cancer Patient Mary Poillion
a photo of the von Weller family
Blog
Giving Hope: Supporting TRI
Blog
Research Trials at TRI
View More Articles